The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-(3R,5R)-5-(2-((5-(4-chloro-2-fluorophenyl)furan-2-yl)methylene)hydrazinyl)piperidine-3-carboxylic acid ID: ALA4559660
PubChem CID: 155557779
Max Phase: Preclinical
Molecular Formula: C17H17ClFN3O3
Molecular Weight: 365.79
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)[C@H]1CNC[C@@H](N/N=C/c2ccc(-c3ccc(Cl)cc3F)o2)C1
Standard InChI: InChI=1S/C17H17ClFN3O3/c18-11-1-3-14(15(19)6-11)16-4-2-13(25-16)9-21-22-12-5-10(17(23)24)7-20-8-12/h1-4,6,9-10,12,20,22H,5,7-8H2,(H,23,24)/b21-9+/t10-,12+/m1/s1
Standard InChI Key: YYGWGRHIEONWKJ-CTQNAWGCSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
36.4411 -22.0870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7254 -21.6766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0122 -22.0912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2965 -21.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2057 -20.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3982 -20.6933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9878 -21.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5417 -22.0204 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1618 -21.4037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7552 -20.6833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9299 -20.6775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5115 -21.3908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9243 -22.1113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7481 -22.1135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1737 -19.9723 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.6865 -21.3865 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
37.1543 -21.6724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8672 -22.0848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5783 -21.6737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.5803 -20.8484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8647 -20.4358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1473 -20.8485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8651 -19.6109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5797 -19.1987 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1509 -19.1980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 4 1 0
7 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
10 15 1 0
12 16 1 0
17 1 1 1
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 23 1 1
23 24 2 0
23 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.79Molecular Weight (Monoisotopic): 365.0942AlogP: 2.73#Rotatable Bonds: 5Polar Surface Area: 86.86Molecular Species: ZWITTERIONHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.66CX Basic pKa: 8.99CX LogP: 0.01CX LogD: 0.00Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.56Np Likeness Score: -1.13
References 1. Hauke TJ, Höfner G, Wanner KT.. (2019) Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4., 27 (1): [PMID:30503411 ] [10.1016/j.bmc.2018.11.028 ]